Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kazi Rubiya Fatema"'
Autor:
Arifa Sultana, Saimon Shahriar, Md. Rafat Tahsin, Sabiha Rahman Mim, Kazi Rubiya Fatema, Ananya Saha, Fahmida Yesmin, Nasiba Binte Bahar, Mithun Samodder, Md. Ariful Haque Mamun, Md. Aknur Rahman, Sonia Ferdousy, Tahmina Akter, Fahima Aktar, Md. Ruhul Kuddus, Md. Mustafizur Rahman, Md. Moklesur Rahman Sarker, Sultan Mehtap Büyüker, Jakir Ahmed Chowdhury, Abu Asad Chowdhury, Shaila Kabir, Md. Akter Hossain, Md. Shah Amran
Publikováno v:
Vaccines, Vol 9, Iss 10, p 1090 (2021)
Background: The Oxford–AstraZeneca vaccine (Covishield) was the first to be introduced in Bangladesh to fight the ongoing global COVID-19 pandemic. As this vaccine had shown some side-effects in its clinical trial, we aimed to conduct a study asses
Externí odkaz:
https://doaj.org/article/9d9623601bb1416abf7520782e69df2f
Autor:
Arifa Sultana, Sabiha Rahman Mim, Ananya Saha, Fahmida Yesmin, Md. Rafat Tahsin, Nasiba Binte Bahar, Kazi Rubiya Fatema, Saimon Shahriar, Kazi Milenur Rahman Prattay, Fazle Rabbi, Fabiha Noushin, Mithun Samodder, Qurratul Ain Sadia, Jannatul Ferdous, Md. Ariful Haque Mamun, Mohammad Ikram Uddin, Tahmina Akter, Md. Mustafizur Rahman, Md. Moklesur Rahman Sarker, Md. Ruhul Kuddus, Fahima Aktar, Jakir Ahmed Chowdhury, Abu Asad Chowdhury, Shaila Kabir, Sultan Mehtap Büyüker, Md. Sohanur Rahman, Md. Habibur Rahman, Md. Shah Amran
Publikováno v:
Environmental Science and Pollution Research. 30:47381-47393
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0da01f6d4b4e808f0fa8b6bdf781dd9
https://doi.org/10.1007/s11356-023-25527-2
https://doi.org/10.1007/s11356-023-25527-2
Autor:
Sonia Ferdousy, Jakir Ahmed Chowdhury, Abu Asad Chowdhury, Aknur Rahman, Ariful Haque Mamun, Sabiha Rahman Mim, Akter Hossain, Nasiba Binte Bahar, Mustafizur Rahman, Md. Moklesur Rahman Sarker, Tahmina Akter, Ruhul Kuddus, Ananya Saha, Rafat Tahsin, Shaila Kabir, Kazi Rubiya Fatema, Saimon Shahriar, Mithun Samodder, Sultan Mehtap Büyüker, Shah Amran, Fahima Aktar, Arifa Sultana, Fahmida Yesmin
Publikováno v:
Vaccines, Vol 9, Iss 1090, p 1090 (2021)
Vaccines
Volume 9
Issue 10
Vaccines
Volume 9
Issue 10
Background: The Oxford–AstraZeneca vaccine (Covishield) was the first to be introduced in Bangladesh to fight the ongoing global COVID-19 pandemic. As this vaccine had shown some side-effects in its clinical trial, we aimed to conduct a study asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c941c448f88246370a34d2ffe32d1689
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-459077
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-459077
